HCC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
HCC
May 15, 2024, 14:07 |
Blog
Rasha Aboelhassan: I'm honoured to be a part of the HCC committee in Nasser Institute
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn: “Management of…
May 7, 2024, 15:35 |
Insight
Arndt Vogel: Excellent summary on precision medicine in HCC
Arndt Vogel shared on X: "Precision treatment in advanced HCC. Excellent summary on precision medicine…
Apr 13, 2024, 14:18 |
Insight
Jonathan Cohen discusses hepatocellular carcinoma at the annual meeting of the Israeli Oncology Society
Jonathan Cohen, Director of Clinical Research at Sharett Institute of Oncology of Hadassah Medical Center,…
Apr 12, 2024, 17:36 |
Insight
Mark Yarchoan: Multicenter P1/2 trial of a personalized neoantigen vaccine + anti-PD1 in 2L HCC presented at AACR24
Mark Yarchoan, Associate Professor at Johns Hopkins Hospital, shared on X: "Multicenter P1/2 trial of…
Apr 10, 2024, 09:52 |
Insight
David Pinato: Immunotherapy might become a novel standard of care in intermediate-stage HCC
David Pinato, Director of Developmental Cancer Therapeutics at Imperial College London, shared on LinkedIn: "Immunotherapy…
Mar 28, 2024, 02:23 |
Drugs
Angela Lamarca: Great news for patients diagnosed with Biliary Malignancies and HCC in Spain
Angela Lamarca, Consultant in Medical Oncology at Jiménez Díaz Foundation University Hospital, shared a post…
Mar 27, 2024, 13:02 |
Blog
Erman Akkus: ESMO-2023, hepatobiliary and pancreatic cancers
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "ESMO-2023, hepatobiliary and pancreatic…
Mar 2, 2024, 12:40 |
Blog
David James Pinato: Immunotherapy is truly changing the way we treat HCC
David James Pinato, Director of Developmental Cancer Therapeutics, Clinical Senior Lecturer and Consultant Medical Oncologist…
Feb 21, 2024, 18:13 |
Insight
Erman Akkus: Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Tremelimumab plus durvalumab (STRIDE)…
Feb 12, 2024, 17:11 |
Blog
Laura Dawson: The SBRT debate was a wonderful way to end the HCC-LIVE Conference
Laura Dawson, Professor & Chair Department Radiation Oncology at the University of Toronto, shared the…
1
2
All:
13
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube